Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation

ConclusionsLira therapy protects against AngII-mediated diastolic dysfunction, at least in part by promoting amino acid uptake and protein turnover in the heart. Liraglutide therapy is associated with loss of mean muscle mass, and long-term studies are warranted to investigate sarcopenia and frailty with liraglutide therapy in the setting of diastolic disease.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research